Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
5
×
glaxosmithkline
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
clinical trials
fda
amgen
cancer
duchenne muscular dystrophy
eli lilly
europe blog main
europe top stories
medical devices
allergan
alzheimer's disease
What
bio
5
×
roundup
days
abbvie’s
day
labor
opioid
ahead
alliance
august
barbecuing
biofourmis
biotech
black
bristol
bucks
busy
buy
calls
camping
cancer
cardiologist
celebrate
center
chance
changing
check
cholesterol
color
companies
conference
continue
corner
crispr
debut
decisions
devices
diamond
diamond’s
drugs
Language
unset
5
×
Current search:
glaxosmithkline
×
bio
×
" detroit top stories "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More